{"id":"https://openalex.org/W2770940237","doi":"https://doi.org/10.1111/dom.13160","title":"Comparison of medication adherence and persistence in type 2 diabetes: A systematic review and meta\u2010analysis","display_name":"Comparison of medication adherence and persistence in type 2 diabetes: A systematic review and meta\u2010analysis","publication_year":2017,"publication_date":"2017-11-14","ids":{"openalex":"https://openalex.org/W2770940237","doi":"https://doi.org/10.1111/dom.13160","mag":"2770940237","pmid":"https://pubmed.ncbi.nlm.nih.gov/29135080"},"language":"en","primary_location":{"id":"doi:10.1111/dom.13160","doi":"https://doi.org/10.1111/dom.13160","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.13160","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13160","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13160","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040557853","display_name":"Andrew Peter McGovern","orcid":"https://orcid.org/0000-0002-6833-9399","observed_orcids":["https://orcid.org/0000-0002-6833-9399"]},"institutions":[{"id":"https://openalex.org/I28290843","display_name":"University of Surrey","ror":"https://ror.org/00ks66431","country_code":"GB","type":"education","lineage":["https://openalex.org/I28290843"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Andrew McGovern","raw_affiliation_strings":["Section of Clinical Medicine and Aging, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK"],"raw_orcid":"https://orcid.org/0000-0002-6833-9399","affiliations":[{"raw_affiliation_string":"Section of Clinical Medicine and Aging, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK","institution_ids":["https://openalex.org/I28290843"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108631887","display_name":"Zayd Tippu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I28290843","display_name":"University of Surrey","ror":"https://ror.org/00ks66431","country_code":"GB","type":"education","lineage":["https://openalex.org/I28290843"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Zayd Tippu","raw_affiliation_strings":["Section of Clinical Medicine and Aging, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Clinical Medicine and Aging, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK","institution_ids":["https://openalex.org/I28290843"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039010948","display_name":"William Hinton","orcid":"https://orcid.org/0000-0003-4927-0901","observed_orcids":["https://orcid.org/0000-0003-4927-0901"]},"institutions":[{"id":"https://openalex.org/I28290843","display_name":"University of Surrey","ror":"https://ror.org/00ks66431","country_code":"GB","type":"education","lineage":["https://openalex.org/I28290843"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"William Hinton","raw_affiliation_strings":["Section of Clinical Medicine and Aging, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Clinical Medicine and Aging, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK","institution_ids":["https://openalex.org/I28290843"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058258192","display_name":"Neil M. Munro","orcid":"https://orcid.org/0000-0003-0150-326X","observed_orcids":["https://orcid.org/0000-0003-0150-326X"]},"institutions":[{"id":"https://openalex.org/I28290843","display_name":"University of Surrey","ror":"https://ror.org/00ks66431","country_code":"GB","type":"education","lineage":["https://openalex.org/I28290843"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Neil Munro","raw_affiliation_strings":["Section of Clinical Medicine and Aging, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Clinical Medicine and Aging, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK","institution_ids":["https://openalex.org/I28290843"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081689241","display_name":"Martin Whyte","orcid":"https://orcid.org/0000-0002-2897-2026","observed_orcids":["https://orcid.org/0000-0002-2897-2026"]},"institutions":[{"id":"https://openalex.org/I28290843","display_name":"University of Surrey","ror":"https://ror.org/00ks66431","country_code":"GB","type":"education","lineage":["https://openalex.org/I28290843"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Martin Whyte","raw_affiliation_strings":["Section of Clinical Medicine and Aging, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Clinical Medicine and Aging, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK","institution_ids":["https://openalex.org/I28290843"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5006687609","display_name":"Simon de Lusignan","orcid":"https://orcid.org/0000-0002-8553-2641","observed_orcids":["https://orcid.org/0000-0002-8553-2641"]},"institutions":[{"id":"https://openalex.org/I28290843","display_name":"University of Surrey","ror":"https://ror.org/00ks66431","country_code":"GB","type":"education","lineage":["https://openalex.org/I28290843"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simon de Lusignan","raw_affiliation_strings":["Section of Clinical Medicine and Aging, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Section of Clinical Medicine and Aging, Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK","institution_ids":["https://openalex.org/I28290843"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5040557853"],"corresponding_institution_ids":["https://openalex.org/I28290843"],"apc_list":{"value":5380,"currency":"USD","value_usd":5380},"apc_paid":null,"fwci":1.8472,"has_fulltext":true,"cited_by_count":172,"citation_normalized_percentile":{"value":0.86528497,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"20","issue":"4","first_page":"1040","last_page":"1043"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.9922000169754028,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.00559999980032444,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10793","display_name":"Diabetes Management and Education","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.8230000138282776},{"id":"https://openalex.org/keywords/medication-persistence","display_name":"treatment persistence","score":0.9319999814033508},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9990000128746033},{"id":"https://openalex.org/keywords/glucose-lowering-medications","display_name":"glucose-lowering medications","score":0.8799999952316284},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.9929999709129333},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9990000128746033},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":1.0},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9559999704360962},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9860000014305115},{"id":"https://openalex.org/keywords/long-acting-insulin-analogues","display_name":"long-acting insulin analogues","score":0.9750000238418579},{"id":"https://openalex.org/keywords/human-insulin","display_name":"human insulin","score":0.9039999842643738},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.6000000238418579}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.893282413482666},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.7204756140708923},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.6980247497558594},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.6656360030174255},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6545868515968323},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.5875424146652222},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.5819078683853149},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.509171187877655},{"id":"https://openalex.org/C2781145037","wikidata":"https://www.wikidata.org/wiki/Q5011772","display_name":"CINAHL","level":3,"score":0.4996378421783447},{"id":"https://openalex.org/C2781009140","wikidata":"https://www.wikidata.org/wiki/Q7170389","display_name":"Persistence (discontinuity)","level":2,"score":0.48577168583869934},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.46548715233802795},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.460247665643692},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.434232622385025},{"id":"https://openalex.org/C2776478404","wikidata":"https://www.wikidata.org/wiki/Q1105187","display_name":"Cochrane Library","level":3,"score":0.4316253662109375},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.38236621022224426},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.359031617641449},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2678910493850708},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.08213484287261963},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.0},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.0},{"id":"https://openalex.org/C187320778","wikidata":"https://www.wikidata.org/wiki/Q1349130","display_name":"Geotechnical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1111/dom.13160","doi":"https://doi.org/10.1111/dom.13160","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.13160","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13160","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},{"id":"pmid:29135080","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29135080","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, obesity & metabolism","raw_type":"Comparative Study"},{"id":"pmh:oai:epubs.surrey.ac.uk:845449","doi":null,"is_oa":false,"landing_page_url":"http://epubs.surrey.ac.uk/845449/1/Comparison%20of%20medication%20adherence%20and%20persistence%20in%20type%202%20diabetes%20A%20systematic%20review%20and%20meta%20analysis%20dom13160.pdf","pdf_url":"http://epubs.surrey.ac.uk/845449/1/Comparison%20of%20medication%20adherence%20and%20persistence%20in%20type%202%20diabetes%20A%20systematic%20review%20and%20meta%20analysis%20dom13160.pdf","source":{"id":"https://openalex.org/S4306400680","display_name":"Surrey Research Insight Open Access (The University of Surrey)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I28290843","host_organization_name":"University of Surrey","host_organization_lineage":["https://openalex.org/I28290843"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1111/dom.13160","doi":"https://doi.org/10.1111/dom.13160","is_oa":true,"landing_page_url":"https://doi.org/10.1111/dom.13160","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/dom.13160","source":{"id":"https://openalex.org/S148394532","display_name":"Diabetes Obesity and Metabolism","issn_l":"1462-8902","issn":["1462-8902","1463-1326"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes, Obesity and Metabolism","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"},{"display_name":"Meta-Analysis","id":"https://openalex.org/study-designs/meta-analysis"}],"awards":[{"id":"https://openalex.org/G305783714","display_name":null,"funder_award_id":"ACF-2017-23-003","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"}],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320327235","display_name":"Servier","ror":"https://ror.org/034e7c066"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2770940237.pdf","grobid_xml":"https://content.openalex.org/works/W2770940237.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W1837867596","https://openalex.org/W1845225129","https://openalex.org/W1979728198","https://openalex.org/W2036387352","https://openalex.org/W2109238714","https://openalex.org/W2115977452","https://openalex.org/W2139062201","https://openalex.org/W2147325147","https://openalex.org/W2160088494","https://openalex.org/W2164733897","https://openalex.org/W2290612843"],"related_works":["https://openalex.org/W7064761165","https://openalex.org/W2805794254","https://openalex.org/W4206717797","https://openalex.org/W2995951612","https://openalex.org/W2333436444","https://openalex.org/W7097084539","https://openalex.org/W2781836119","https://openalex.org/W2056824040","https://openalex.org/W2290612843","https://openalex.org/W2481162159"],"abstract_inverted_index":{"Limited":[0],"medication":[1],"adherence":[2,40,77,96,128,143,190],"and":[3,30,34,111,146,191],"persistence":[4,42,173,192],"with":[5,44,52,94],"treatment":[6],"are":[7],"barriers":[8],"to":[9,122,129,188],"successful":[10],"management":[11],"of":[12,26,90,155],"type":[13],"2":[14,45],"diabetes":[15],"(T2D).":[16],"We":[17,86],"searched":[18],"MEDLINE,":[19],"EMBASE,":[20],"the":[21,24,39,60,82],"Cochrane":[22],"Library,":[23],"Register":[25],"Controlled":[27],"Trials,":[28],"PsychINFO":[29],"CINAHL":[31],"for":[32,76,100],"observational":[33],"interventional":[35],"studies":[36,58],"that":[37],"compared":[38],"or":[41,46,56,72,78],"associated":[43],"more":[47,57],"glucose-lowering":[48],"medications":[49],"in":[50],"people":[51],"T2D.":[53],"Where":[54],"5":[55],"provided":[59],"same":[61],"comparison,":[62],"a":[63,88],"random-effects":[64],"meta-analysis":[65],"was":[66,98,124],"performed,":[67],"reporting":[68],"mean":[69],"difference":[70],"(MD)":[71],"odds":[73],"ratio":[74],"(OR)":[75],"persistence,":[79],"depending":[80],"on":[81],"pooled":[83],"study":[84],"outcomes.":[85],"included":[87],"total":[89],"48":[91],"studies.":[92],"Compared":[93],"metformin,":[95],"(%)":[97],"better":[99,126,142,172],"sulphonylureas":[101,130,145],"(5":[102,131,177],"studies;":[103,115,132,162,178],"MD":[104,116,133,179],"10.6%,":[105],"95%":[106,118,135,165,182],"confidence":[107],"interval":[108],"[CI]":[109],"6.5-14.7)":[110],"thiazolidinediones":[112],"(TZDs;":[113],"6":[114],"11.3%,":[117],"CI":[119,136,166,183],"2.7%-20.0%).":[120],"Adherence":[121],"TZDs":[123],"marginally":[125],"than":[127,144,157,174],"1.5%,":[134],"0.1-2.9).":[137],"Dipeptidyl":[138],"peptidase-4":[139],"inhibitors":[140],"had":[141,152,171],"TZDs.":[147],"Glucagon-like":[148],"peptide-1":[149],"receptor":[150],"agonists":[151],"higher":[153],"rates":[154],"discontinuation":[156],"long-acting":[158],"analogue":[159],"insulins":[160,176],"(6":[161],"OR":[163],"1.95;":[164],"1.17-3.27).":[167],"Long-acting":[168],"insulin":[169],"analogues":[170],"human":[175],"43.1":[180],"days;":[181],"22.0-64.2).":[184],"The":[185],"methods":[186],"used":[187],"define":[189],"were":[193],"highly":[194],"variable.":[195]},"counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":24},{"year":2024,"cited_by_count":28},{"year":2023,"cited_by_count":28},{"year":2022,"cited_by_count":21},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":18},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":15}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2017-12-04T00:00:00"}